LONG-ACTING FORMULATIONS OF INSULIN GLARGINE

The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Isabell Schoettle, Katrin Tertsch, Reinhard Becker, Petra Loos, Annke Frick, Ulrich Werner, Christiane Fuerst, Peter Boderke, Werner Mueller
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.